1-({4-[(4-chlorophenyl)sulfanyl]-3-nitrophenyl}methyl)-4-(diphenylmethyl)piperazine

Catalog No. :
ACBIAD523
CAS No. :
477869-46-8
Molecular Formula :
C30H28ClN3O2S
Molecular Weight :
530.09

IUPAC Name:1-benzhydryl-4-(4-((4-chlorophenyl)thio)-3-nitrobenzyl)piperazine

1-({4-[(4-chlorophenyl)sulfanyl]-3-nitrophenyl}methyl)-4-(diphenylmethyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$291.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-({4-[(4-chlorophenyl)sulfanyl]-3-nitrophenyl}methyl)-4-(diphenylmethyl)piperazine
IUPAC Name1-benzhydryl-4-(4-((4-chlorophenyl)thio)-3-nitrobenzyl)piperazine
MDL No.MFCD02082150
Molecular FormulaC30H28ClN3O2S
Molecular Weight530.09
SMILESO=[N+](C1=CC(CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=CC=C1SC5=CC=C(Cl)C=C5)[O-]
InChI KeyBAVDRKNLIQWVIM-UHFFFAOYSA-N
Synonym4-[(4-BENZHYDRYLPIPERAZINO)METHYL]-2-NITROPHENYL 4-CHLOROPHENYL SULFIDE;1-BENZHYDRYL-4-(4-[(4-CHLOROPHENYL)SULFANYL]-3-NITROBENZYL)PIPERAZINE;1-({4-[(4-chlorophenyl)sulfanyl]-3-nitrophenyl}methyl)-4-(diphenylmethyl)piperazine;Piperazine, 1-[[4-[(4-chlorophenyl)thio]-3-nitrophenyl]methyl]-4-(diphenylmethyl)-
CAS No.477869-46-8

Synthetic Route by SureRoute

1. ACBIAD523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONZR821 route compound structure diagram
    ACONZR821841-77-0 In Stock
  4. Then
  5. ACBIAD523 route product structure diagram
    ACBIAD523477869-46-8
Inquiry

2. ACBIAD523 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACONZR821 route compound structure diagram
    ACONZR821841-77-0 In Stock
  4. Then
  5. ACBIAD523 route product structure diagram
    ACBIAD523477869-46-8
Inquiry

Comments (0)